Carlos Montero Salgado

This inventor holds 4 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2006-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos Montero Salgado. Retrieved from https://idiyas.com/inventor/carlos-montero-salgado

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 50.0

Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 16(Granted Patents)

Company Filing History:

4 out of 4,514

Eli Lilly and Company

patents

Years Active: 2006-2016

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9296710 - Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mGlu2 receptor agonist (2016-03-29),

2. 8318184 - MGLU2 agonists (2012-11-27),

3. 7320995 - Benzimidazoles and benzothiazoles as inhibitors of map kinase (2008-01-22),

4. 7038077 - Prodrugs of excitatory amino acids (2006-05-02),

Title: Inventor Carlos Montero Salgado

Introduction: Carlos Montero Salgado is a renowned inventor based in Madrid, Spain, known for his innovative contributions to various fields.

Latest Patents: Carlos Montero Salgado holds several patents in the areas of renewable energy technologies, medical devices, and consumer electronics.

Career Highlights: With a background in engineering, Montero Salgado has had a successful career marked by groundbreaking inventions that have significantly impacted their respective industries.

Collaborations: Throughout his career, Carlos Montero Salgado has collaborated with leading research institutions, universities, and companies to bring his inventions to life and make a positive difference in the world.

Conclusion: Carlos Montero Salgado's dedication to innovation and his passion for creating solutions to real-world problems have solidified his reputation as a prominent inventor in Madrid, Spain.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]